After two failed takeover processes, a Takeovers Panel ruling and a boardroom overhaul, fund managers argue the lender's value has been trapped by governance rather than performance, and that asset sales could release it.
Investors Mutual Limited reduced their position in CSL Ltd after the global biotech company's share price rebounded 62.5% over the September 2026 quarter.
More increasesMore reductionsBothHeld onlyDarker means more comments
General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
12,245 comments from 167 managers on 777 companies, snapshot 30 Oct 2026.
After two failed takeover processes, a Takeovers Panel ruling and a boardroom overhaul, fund managers argue the lender's value has been trapped by governance rather than performance, and that asset sales could release it.
Investors Mutual Limited reduced their position in CSL Ltd after the global biotech company's share price rebounded 62.5% over the September 2026 quarter.
More increasesMore reductionsBothHeld onlyDarker means more comments
General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
12,245 comments from 167 managers on 777 companies, snapshot 30 Oct 2026.